CD109 is highly expressed in osteosarcoma, promote tumor cell migration via suppression of bone morphogenetic protein-2 (BMP-2)-induced Smad1/5/9 phosphorylation, where its expression correlates with poor prognosis (84). This evidence concerns the gene CD109 and neoplasm.